Latest papers

Silent somatotroph adenoma of the pituitary in an adolescent.

Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas.

Survivin products in pituitary tumors.

[Pregnancy in active acromegaly].

Sublabial transseptal approach to pituitary adenomas with special emphasis on rhinological complications.

Diagnosis: pituitary gigantism in a 2 1/2-year old child.

Growth hormone-secreting tumor shrinkage after 3 months of octreotide-long-acting release therapy predicts the response at 12 months.

Estrogen receptors in human pituitary tumors.

Short-lasting, unilateral neuralgiform headache attacks with conjunctival injection and tearing syndrome treated successfully with transsphenoidal resection of a growth hormone-secreting pituitary adenoma.

Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.

[Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].

Biochemical cure of acromegaly after transsphenoidal surgery despite residual tumor on magnetic resonance imaging: case report.

The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma.

Octreotide LAR for the treatment of acromegaly.

Transsphenoidal surgery for pituitary adenoma in elderly patients.

Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.

A growth hormone-secreting adenoma with incomplete nerve bundle formation.

Genetic abnormalities of somatostatin receptors in pituitary tumors.

Pituitary adenomas in northern Sweden: a study on therapy choices and the risk of second primary tumours.

Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas.